Sitemap
- Latest News
- CPHI Milan 2024
- DCAL at iPHEX 2024 - India's Largest Global Pharmaceutical Exhibition
- Dishman Carbogen Amcis receives 'Choose France - Best Indian Investment in France' award from the Indo French Chamber of Commerce and Industry (IFFCI)
- DCAL's Bavla plant gets PMDA approval
- DISHMAN CARBOGEN AMCIS OPENS OFFICE IN KYOTO, JAPAN
- Dishman Carbogen Amcis Statement on COVID-19
- CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France
- Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India
- ISO22716 Cosmetics GMP standard accreditation
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency
- Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
“Dishman Group” is not a separate legal entity but nomenclature used in generality for Dishman Carbogen Amcis Limited, the flagship Company, and its Indian and foreign subsidiaries, joint ventures and associate companies across the globe. All these entities are individual and separate by the law.
